Interferon β-1b and glatiramer acetate effects on permanent black hole evolution - Wikidata - wikimedia - TriplyDB

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

http://www.wikidata.org/entity/Q34743156

about

Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis Multiple sclerosis imaging: recent advances.The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.Defining Disease Activity and Response to Therapy in MS.Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients.Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis Neurological diseases in relation to the blood-brain barrier.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.[Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.

P2860

Q24194800-4DB6F803-3387-48DE-A929-C190EC058124 Q26752859-E0B1CCFC-5302-4BAF-84E1-F6E5E35BDC9E Q28299160-5DB467B1-4E55-4B3F-A844-12451B480A5D Q33988240-4CFDA8DB-A532-480F-8038-0A89D9D6793F Q34090086-93A5DBD5-2345-4972-B68D-FE495329648D Q34253488-2C260AC6-B75B-4217-B59C-9A36758B7D4E Q34522015-C24E38F9-35A5-433A-9A9E-2E6A9F031C3D Q35621233-B8F38B65-B66F-4B2A-9D9B-DBB35EF244D1 Q36202727-54598773-F737-4FD2-83DC-09FCD1A4712D Q36357501-B15ADA5D-056F-48D5-8AD2-7BD3BA014E8A Q37001347-8F030823-41B5-468C-A400-4DC2BE310983 Q37221728-C949BDB2-3E5E-4915-94D0-29712336B316 Q37320255-599DA8E8-B65F-41C2-ADDB-F6F63514220D Q37976564-21E0CC76-2BE2-4698-953E-6404607CE0DD Q38152977-7CBA006E-FFB0-4FFD-8CE7-441095C80A13 Q38444650-7259496F-D4DA-47AB-B883-09326BAA6058 Q38449394-39942D3A-DDBA-435B-A05A-DF0C774CCD65 Q41647429-CB4713AF-F1EE-4C9E-871B-3FE453A14407 Q42339266-7AD39538-48E8-45C9-B4D7-83E840E308C7 Q45155454-CE8EC615-C595-4FE0-B5D0-31B48A058E1B Q48031815-105F6C1A-66E8-4193-9C91-59724A42393C

P2860

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

http://www.wikidata.org/entity/Q34743156

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@ast

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@en

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@nl

type

label

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@ast

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@en

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@nl

prefLabel

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@ast

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@en

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@nl

P1433

Q34743156-2379249A-3668-4B36-B5D1-6D00668FBD20

P1476

Q34743156-542504DE-AD88-4391-8F9F-55B6E59754DD

P2093

Q34743156-02365A7E-F8DE-4C6B-B5A7-963D6384B050

Q34743156-1451DD3E-AC68-474D-8EAB-3EF787E77F6C

Q34743156-17B841AA-8674-4B3C-A519-92FC5CE2119A

Q34743156-2031934B-77D6-46FE-811B-480E65625078

Q34743156-20E437F9-B09F-4DBA-A34B-A39065700E29

Q34743156-59DD8C2B-6D0C-4880-9B3A-83172BF09BA7

Q34743156-66CB86B1-64C9-437E-AC6A-38A6FA7D875F

Q34743156-6E99F78C-5FC6-4B4A-9283-4ED7901F8E9D

Q34743156-8CF9E295-A426-42AC-BA97-F4C2F4DD731C

Q34743156-95972CE6-D1F2-4236-B55E-3BE26E2C268F

P2860

Q34743156-03F0CEEA-E530-4166-9171-E83A4F138883

Q34743156-2605DF84-BC34-4DA7-9AB8-90C1706901AB

Q34743156-29C50D24-4668-4ED8-A66D-CC3E07C710AA

Q34743156-3FD66867-654D-4291-9688-050B4FB82BEB

Q34743156-4B42731A-9168-41C7-B23C-7CCA9151BC58

Q34743156-5B06ED41-EE58-4798-A3F5-8A5206B9A057

Q34743156-5DE55AAB-DA57-4D14-A444-CF6ACD0747D7

Q34743156-5F21FB89-2744-49FD-B4A0-4D6B72475A2F

Q34743156-6B7C7210-995B-4D49-9BE3-E6F51F9EC140

Q34743156-781CC260-BD15-442D-9080-610D16711622

P304

Q34743156-4DE951DC-44C1-4AC0-8E25-081CC2F23C94

P31

Q34743156-4549BFF1-ABBA-4B25-96DE-8B89ECA3BFB2

P356

Q34743156-47F9C539-40EB-4969-956E-1DEF3BD3F001

P407

Q34743156-7C4A808E-0E0A-4D30-9283-FA5DE4A66836

P433

Q34743156-E7D688E9-AECF-4C89-B574-FC7CE27CC09B

P478

Q34743156-1BAC7B85-433C-4F42-AB32-01FC12D4FC4C

P50

Q34743156-03A98A50-ADE7-4272-AC2F-7DBC29F4D817

Q34743156-62CA1AEF-C1A0-463B-B0A7-3A5E0C73C61A

P577

Q34743156-8C83CDDF-07CA-480C-8BF0-932B4D51831A

P698

Q34743156-DEAB922B-FB51-4054-A013-CCC5D9851399

P921

Q34743156-44d3ae8d-4528-581e-9edc-3580571835e4

Q34743156-8F6F9680-C592-4340-99DE-6F49FD73CFA6

P932

Q34743156-77B53E30-5241-4D1C-868C-A518AB2E0D50

P356

WNL.0B013E3182143577

P1433

P1476

Interferon β-1b and glatiramer acetate effects on permanent black hole evolution

@en

P2093

B G W Arnason

http://www.w3.org/2001/XMLSchema#string

C Brown

http://www.w3.org/2001/XMLSchema#string

C Pohl

http://www.w3.org/2001/XMLSchema#string

D Goodin

http://www.w3.org/2001/XMLSchema#string

D Jeffery

http://www.w3.org/2001/XMLSchema#string

D L Arnold

http://www.w3.org/2001/XMLSchema#string

E Croze

http://www.w3.org/2001/XMLSchema#string

F Camesasca

http://www.w3.org/2001/XMLSchema#string

G Comi

http://www.w3.org/2001/XMLSchema#string

G Cutter

http://www.w3.org/2001/XMLSchema#string

P2860

T1 hypointensities and axonal loss.

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate.

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.

Black holes in multiple sclerosis: definition, evolution, and clinical correlations.

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadi

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.

P304

1222-1228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182143577

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Filippi

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21464426

http://www.w3.org/2001/XMLSchema#string

P921

glatiramer acetate

Interferón β-1b

P932

3068007

http://www.w3.org/2001/XMLSchema#string